Ocean Biomedical Stock Return On Equity

OCEA Stock   0.58  0.05  7.94%   
Ocean Biomedical fundamentals help investors to digest information that contributes to Ocean Biomedical's financial success or failures. It also enables traders to predict the movement of Ocean Stock. The fundamental analysis module provides a way to measure Ocean Biomedical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ocean Biomedical stock.
Last ReportedProjected for Next Year
Return On Equity 0.01  0.01 
As of December 18, 2024, Return On Equity is expected to decline to 0.01.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Ocean Biomedical Company Return On Equity Analysis

Ocean Biomedical's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Current Ocean Biomedical Return On Equity

    
  0.005923  
Most of Ocean Biomedical's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ocean Biomedical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Ocean Return On Equity Driver Correlations

Understanding the fundamental principles of building solid financial models for Ocean Biomedical is extremely important. It helps to project a fair market value of Ocean Stock properly, considering its historical fundamentals such as Return On Equity. Since Ocean Biomedical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Ocean Biomedical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Ocean Biomedical's interrelated accounts and indicators.

Ocean Return On Equity Historical Pattern

Today, most investors in Ocean Biomedical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Ocean Biomedical's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's return on equity growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Ocean Biomedical return on equity as a starting point in their analysis.
   Ocean Biomedical Return On Equity   
       Timeline  
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Ocean Total Stockholder Equity

Total Stockholder Equity

(86.22 Million)

At present, Ocean Biomedical's Total Stockholder Equity is projected to decrease significantly based on the last few years of reporting.

Ocean Return On Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ocean Biomedical's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ocean Biomedical could also be used in its relative valuation, which is a method of valuing Ocean Biomedical by comparing valuation metrics of similar companies.
Ocean Biomedical is currently under evaluation in return on equity category among its peers.

Ocean Fundamentals

About Ocean Biomedical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Ocean Biomedical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ocean Biomedical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ocean Biomedical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Ocean Biomedical is a strong investment it is important to analyze Ocean Biomedical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ocean Biomedical's future performance. For an informed investment choice regarding Ocean Stock, refer to the following important reports:
Check out Ocean Biomedical Piotroski F Score and Ocean Biomedical Altman Z Score analysis.
For information on how to trade Ocean Stock refer to our How to Trade Ocean Stock guide.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocean Biomedical. If investors know Ocean will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocean Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.00)
Return On Assets
(6.82)
The market value of Ocean Biomedical is measured differently than its book value, which is the value of Ocean that is recorded on the company's balance sheet. Investors also form their own opinion of Ocean Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Ocean Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocean Biomedical's market value can be influenced by many factors that don't directly affect Ocean Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocean Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocean Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocean Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.